1. Home
  2. DOCN vs CYTK Comparison

DOCN vs CYTK Comparison

Compare DOCN & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DigitalOcean Holdings Inc.

DOCN

DigitalOcean Holdings Inc.

BUY

Current Price

$93.28

Market Cap

13.2B

Sector

Technology

ML Signal

BUY

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$61.48

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOCN
CYTK
Founded
2011
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
10.7B
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
DOCN
CYTK
Price
$93.28
$61.48
Analyst Decision
Buy
Strong Buy
Analyst Count
17
23
Target Price
★ $176.20
$109.40
AVG Volume (30 Days)
★ 2.1M
1.8M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 183.15
N/A
EPS
★ 0.45
N/A
Revenue
★ $901,427,000.00
$13,368,000.00
Revenue This Year
$30.79
$72.63
Revenue Next Year
$54.38
$181.06
P/E Ratio
$204.11
★ N/A
Revenue Growth
★ 15.48
N/A
52 Week Low
$37.84
$57.92
52 Week High
$187.50
$88.31

Technical Indicators

Market Signals
Indicator
DOCN
CYTK
Relative Strength Index (RSI) 30.68 37.55
Support Level $73.66 $59.21
Resistance Level $94.24 $66.63
Average True Range (ATR) 9.38 1.98
MACD -3.85 0.33
Stochastic Oscillator 8.78 31.89

Price Performance

Historical Comparison
DOCN
CYTK

About DOCN DigitalOcean Holdings Inc.

DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: